PeptideDB

GS-6620 PM

CAS No.: 1191237-49-6

GS-6620 PM is a derivative of GS-6620, an orally administered anti-hepatitis C virus polymerase inhibitor and a novel po
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description GS-6620 PM is a derivative of GS-6620, an orally administered anti-hepatitis C virus polymerase inhibitor and a novel potent C-nucleoside adenine analogue monophosphate prodrug.GS-6620 has limited activity against other viruses and maintains only partial activity against the closely related bovine viral diarrhea virus (EC50, 1.5 μM).
molecular weight 305.29
Molecular formula C13H15N5O4
CAS 1191237-49-6
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility DMSO: 45 mg/mL (147.4 mM)
References 1. Cho A, et al. Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patients. J Med Chem. 2014;57(5):1812-1825.